128 related articles for article (PubMed ID: 37244061)
1. Cerebrospinal fluid erythropoietin, oxidative stress, and cognitive functions in patients with bipolar disorder and healthy control participants: A longitudinal case-control study.
Miskowiak KW; Simonsen AH; Meyer M; Poulsen HE; Wilkan M; Forman J; Hasselbalch SG; Kessing LV; Knorr U
J Psychiatr Res; 2023 Jul; 163():240-246. PubMed ID: 37244061
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study.
Knorr U; Simonsen AH; Roos P; Weimann A; Henriksen T; Christensen EM; Vinberg M; Mikkelsen RL; Kirkegaard T; Jensen RN; Akhøj M; Forman J; Poulsen HE; Hasselbalch SG; Kessing LV
Transl Psychiatry; 2019 Nov; 9(1):325. PubMed ID: 31780642
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for neurodegeneration impact cognitive function: a longitudinal 1-year case-control study of patients with bipolar disorder and healthy control individuals.
Knorr U; Simonsen AH; Zetterberg H; Blennow K; Willkan M; Forman J; Miskowiak K; Hasselbalch SG; Kessing LV
Int J Bipolar Disord; 2024 Jan; 12(1):2. PubMed ID: 38227084
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.
Petersen JZ; Schmidt LS; Vinberg M; Jørgensen MB; Hageman I; Ehrenreich H; Knudsen GM; Kessing LV; Miskowiak KW
Trials; 2018 Nov; 19(1):611. PubMed ID: 30400939
[TBL] [Abstract][Full Text] [Related]
5. A comparative meta-analysis of peripheral 8-hydroxy-2'-deoxyguanosine (8-OHdG) or 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG) levels across mood episodes in bipolar disorder.
Çeli K HEA; Tuna G; Ceylan D; Küçükgöncü S
Psychoneuroendocrinology; 2023 May; 151():106078. PubMed ID: 36931055
[TBL] [Abstract][Full Text] [Related]
6. Alterations in levels of 8-Oxo-2'-deoxyguanosine and 8-Oxoguanine DNA glycosylase 1 during a current episode and after remission in unipolar and bipolar depression.
Ceylan D; Yılmaz S; Tuna G; Kant M; Er A; Ildız A; Verim B; Akış M; Akan P; İşlekel H; Veldic M; Frye M; Özerdem A
Psychoneuroendocrinology; 2020 Apr; 114():104600. PubMed ID: 32062372
[TBL] [Abstract][Full Text] [Related]
7. Cognitive deficits in bipolar disorders: Implications for emotion.
Lima IMM; Peckham AD; Johnson SL
Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
[TBL] [Abstract][Full Text] [Related]
8. Associations between oxidative stress and perceived stress in patients with bipolar disorder and healthy control individuals.
Knorr U; Blom RA; Simonsen AH; Poulsen HE; Akhøj M; Forman J; Hasselbalch SG; Kessing LV
Nord J Psychiatry; 2021 Oct; 75(7):532-537. PubMed ID: 33781161
[TBL] [Abstract][Full Text] [Related]
9. The effect of erythropoietin on cognition in affective disorders - Associations with baseline deficits and change in subjective cognitive complaints.
Ott CV; Vinberg M; Kessing LV; Miskowiak KW
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1264-73. PubMed ID: 27349944
[TBL] [Abstract][Full Text] [Related]
10. Higher systemic oxidatively generated DNA and RNA damage in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives.
Coello K; Bøgh HL; Stanislaus S; Kjærstad HL; Melbye SA; Ormstrup Sletved KS; Poulsen HE; Vinberg M; Kessing LV
Free Radic Biol Med; 2021 May; 168():226-233. PubMed ID: 33798615
[TBL] [Abstract][Full Text] [Related]
11. Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin.
Miskowiak KW; Rush AJ; Gerds TA; Vinberg M; Kessing LV
J Clin Psychiatry; 2016 Dec; 77(12):e1639-e1646. PubMed ID: 27835716
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease related biomarkers in bipolar disorder - A longitudinal one-year case-control study.
Knorr U; Simonsen AH; Jensen CS; Zetterberg H; Blennow K; Akhøj M; Forman J; Hasselbalch SG; Kessing LV
J Affect Disord; 2022 Jan; 297():623-633. PubMed ID: 34728295
[TBL] [Abstract][Full Text] [Related]
13. Neural correlates of improved executive function following erythropoietin treatment in mood disorders.
Miskowiak KW; Vinberg M; Glerup L; Paulson OB; Knudsen GM; Ehrenreich H; Harmer CJ; Kessing LV; Siebner HR; Macoveanu J
Psychol Med; 2016 Jun; 46(8):1679-91. PubMed ID: 26996196
[TBL] [Abstract][Full Text] [Related]
14. Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders.
Miskowiak KW; Vinberg M; Macoveanu J; Ehrenreich H; Køster N; Inkster B; Paulson OB; Kessing LV; Skimminge A; Siebner HR
Biol Psychiatry; 2015 Aug; 78(4):270-7. PubMed ID: 25641635
[TBL] [Abstract][Full Text] [Related]
15. Associations between oxidative stress markers and patient-reported smartphone-based symptoms in patients newly diagnosed with bipolar disorder: An exploratory study.
Stanislaus S; Faurholt-Jepsen M; Vinberg M; Poulsen HE; Kessing LV; Coello K
Eur Neuropsychopharmacol; 2022 Sep; 62():36-45. PubMed ID: 35896055
[TBL] [Abstract][Full Text] [Related]
16. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
Miskowiak KW; Vinberg M; Harmer CJ; Ehrenreich H; Knudsen GM; Macoveanu J; Hansen AR; Paulson OB; Siebner HR; Kessing LV
Trials; 2010 Oct; 11():97. PubMed ID: 20942940
[TBL] [Abstract][Full Text] [Related]
17. Effects of erythropoietin on body composition and fat-glucose metabolism in patients with affective disorders.
Vinberg M; Højman P; Pedersen BK; Kessing LV; Miskowiak KW
Acta Neuropsychiatr; 2018 Dec; 30(6):342-349. PubMed ID: 29880069
[TBL] [Abstract][Full Text] [Related]
18. The impact of the trajectory of bipolar disorder on global cognitive function: A one-year clinical prospective case-control study.
Knorr U; Miskowiak K; Akhøj M; Vinberg M; Forman J; Kessing LV
J Affect Disord; 2021 Jan; 278():189-198. PubMed ID: 32961415
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid synaptic biomarker changes in bipolar disorder - A longitudinal case-control study.
Knorr U; Simonsen AH; Nilsson J; Brinkmalm A; Zetterberg H; Blennow K; Knudsen MB; Forman J; Hasselbalch SG; Kessing LV
J Affect Disord; 2024 Aug; 358():250-259. PubMed ID: 38723679
[TBL] [Abstract][Full Text] [Related]
20. Increased DNA and RNA damage by oxidation in patients with bipolar I disorder.
Jacoby AS; Vinberg M; Poulsen HE; Kessing LV; Munkholm K
Transl Psychiatry; 2016 Aug; 6(8):e867. PubMed ID: 27505230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
